Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Operating Expenses (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Operating Expenses for 16 consecutive years, with $6.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses fell 26.27% to $6.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.9 million, a 4.75% increase, with the full-year FY2024 number at $29.1 million, up 8.81% from a year prior.
  • Operating Expenses was $6.4 million for Q3 2025 at GeoVax Labs, up from $6.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $13.9 million in Q4 2021 to a low of $1.6 million in Q2 2021.
  • A 5-year average of $5.7 million and a median of $5.9 million in 2024 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: skyrocketed 775.47% in 2021, then plummeted 61.27% in 2022.
  • GeoVax Labs' Operating Expenses stood at $13.9 million in 2021, then tumbled by 61.27% to $5.4 million in 2022, then surged by 42.81% to $7.7 million in 2023, then rose by 19.69% to $9.2 million in 2024, then plummeted by 30.79% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Operating Expenses are $6.4 million (Q3 2025), $6.3 million (Q2 2025), and $7.0 million (Q1 2025).